LAMEA Meningococcal Vaccine Market

LAMEA Meningococcal Vaccine Market By Brand (Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands), By Type (Bivalent, Quadrivalent and Other Types), By Age Group (Infants (0 to 2 years) and Children (2 years & above)), By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-5328 Publication Date: February-2021 Number of Pages: 78
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Meningococcal Vaccine Market, by Brand
1.4.2 LAMEA Meningococcal Vaccine Market, by Type
1.4.3 LAMEA Meningococcal Vaccine Market, by Age Group
1.4.4 LAMEA Meningococcal Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Developments in Meningococcal Vaccine Market

Chapter 4. LAMEA Meningococcal Vaccine Market by Brand
4.1 LAMEA Bexsero Market by Country
4.2 LAMEA Trumenba Market by Country
4.3 LAMEA Nimenrix Market by Country
4.4 LAMEA Menactra Market by Country
4.5 LAMEA Menveo Market by Country
4.5.1.1 LAMEA Other Brands Market by Country

Chapter 5. LAMEA Meningococcal Vaccine Market by Type
5.1 LAMEA Bivalent Market by Country
5.2 LAMEA Quadrivalent Market by Country
5.3 LAMEA Other Types Market by Country

Chapter 6. LAMEA Meningococcal Vaccine Market by Age Group
6.1 LAMEA Children (2 years & above) and Adults Market by Country
6.2 LAMEA Infants(0 to 2 years) Market by Country

Chapter 7. LAMEA Meningococcal Vaccine Market by Country
7.1 Brazil Meningococcal Vaccine Market
7.1.1 Brazil Meningococcal Vaccine Market by Brand
7.1.2 Brazil Meningococcal Vaccine Market by Type
7.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.2 Argentina Meningococcal Vaccine Market
7.2.1 Argentina Meningococcal Vaccine Market by Brand
7.2.2 Argentina Meningococcal Vaccine Market by Type
7.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.3 UAE Meningococcal Vaccine Market
7.3.1 UAE Meningococcal Vaccine Market by Brand
7.3.2 UAE Meningococcal Vaccine Market by Type
7.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4 Saudi Arabia Meningococcal Vaccine Market
7.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.5 South Africa Meningococcal Vaccine Market
7.5.1 South Africa Meningococcal Vaccine Market by Brand
7.5.2 South Africa Meningococcal Vaccine Market by Type
7.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.6 Nigeria Meningococcal Vaccine Market
7.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.6.2 Nigeria Meningococcal Vaccine Market by Type
7.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.7 Rest of LAMEA Meningococcal Vaccine Market
7.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group

Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo